US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Jaguar Animal Health

2.14

+0.04001.90%

Post-market: 2.140.00000.00%19:18 EDT

Volume:50.11K

Turnover:106.81K

Market Cap:4.10M

PE:-0.02

High:2.20

Open:2.10

Low:2.02

Close:2.10

52wk High:35.25

52wk Low:1.93

Shares:1.91M

Float Shares:1.78M

Volume Ratio:0.99

T/O Rate:2.81%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-130.6878

EPS(LYR):-130.6878

ROE:-459.52%

ROA:-37.48%

PB:2.30

PE(LYR):-0.02

Loading ...

Overview Company News Filings

Jaguar Health Inc expected to post a loss of $7.13 a share - Earnings Preview

Jaguar Health Inc. Announces Date for 2025 Annual Stockholders Meeting

Jaguar Health Inc. Advances European Approval Process for Canalevia with EMA Dossier Submission for General Diarrhea Treatment in Dogs

Jaguar Health announces coca access, benefit sharing agreement authorization

Jaguar Health Inc. Announces Amendment to Existing Royalty Interest Agreement with Iliad Research, Reducing Outstanding Balance by $4.25 Million

Jaguar Health Announces Promising Results from Crofelemer Clinical Trials in Intestinal Failure Patients, Plans for Expedited Regulatory Approval

Jaguar Health Inc. Pursues EMA Approval for Canalevia to Treat General Diarrhea in Dogs Across EU

Jaguar Health Inc. Extends Maturity Date of Convertible Promissory Notes to January 30, 2026

Jaguar Health Inc. Announces Progress in Clinical Trials for Crofelemer, Targeting Intestinal Failure in Rare Diseases

Jaguar Health files to sell 507.4K shares of common stock for holders

Jaguar Health Inc. to Present at the Emerging Growth Conference for Updates on Near-Term Catalysts

Jaguar Health Inc. Establishes First Study Site for Canalevia-CA1 Field Study Amid Ongoing FDA Review for Expanded Canine Diarrhea Treatment Approval

Jaguar Health Pursues FDA Orphan Drug Designation and Expanded Access for Crofelemer in Metastatic Breast Cancer Treatment

Jaguar Health Inc. to Participate in Virtual Fireside Chat at Lytham Partners' Spring 2025 Spotlight Series

Jaguar Health Inc. Releases Investor Presentation Highlighting Operational Strategies and Financial Overview

Jaguar Health Prices Offering of Shares, Warrants

MT Newswires Live

Jaguar Health prices 246,306 shares at $6.09 in registered direct offering

Jaguar Health Inc. Announces $1.5 Million Registered Direct Offering, Issuing 246,306 Shares at $6.09 Each

Jaguar Health announces first patient randomized in crofelemer trial

Jaguar Health Inc. Launches Phase 2 Clinical Trial for Crofelemer in Pediatric MVID Patients

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/JAGX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"JAGX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JAGX\",,,,,undefined,":{"symbol":"JAGX","market":"US","secType":"STK","nameCN":"Jaguar Animal Health","latestPrice":2.14,"timestamp":1754683200000,"preClose":2.1,"halted":0,"volume":50107,"hourTrading":{"tag":"盘后","latestPrice":2.14,"preClose":2.14,"latestTime":"19:18 EDT","volume":137,"amount":292.385,"timestamp":1754695122618},"delay":0,"floatShares":1780300,"shares":1914430,"eps":-130.6878,"marketStatus":"Market Closed","change":0.04,"latestTime":"08-08 16:00:00 EDT","open":2.1,"high":2.1988,"low":2.02,"amount":106808.94805109999,"amplitude":0.085143,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-130.6878,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754899200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1431489600000,"exchange":"NASDAQ","adjPreClose":2.1,"preHourTrading":{"tag":"盘前","latestPrice":2.05,"preClose":2.1,"latestTime":"09:06 EDT","volume":75,"amount":157.24999499999998,"timestamp":1754658362022},"postHourTrading":{"tag":"盘后","latestPrice":2.14,"preClose":2.14,"latestTime":"19:18 EDT","volume":137,"amount":292.385,"timestamp":1754695122618},"volumeRatio":0.9858129182484391,"impliedVol":3.1923,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JAGX\",,,,,undefined,":{"symbol":"JAGX","floatShares":1780300,"roa":"-37.48%","roe":"-459.52%","lyrEps":-130.687798,"volumeRatio":0.9858129182484391,"shares":1914430,"dividePrice":0,"high":2.1988,"amplitude":0.085143,"preClose":2.1,"low":2.02,"week52Low":1.9301,"pbRate":"2.30","psRate":"0.35","week52High":35.25,"institutionHeld":0,"latestPrice":2.14,"eps":-130.6878,"divideRate":0,"volume":50107,"delay":0,"ttmEps":-130.6878,"open":2.1,"prevYearClose":25.25,"prevWeekClose":1.98,"prevMonthClose":2.04,"prevQuarterClose":2.52,"fiveDayClose":1.98,"twentyDayClose":2.7,"sixtyDayClose":6.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JAGX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"JAGX","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-16.7},{"date":"2025-03-31","symbol":"JAGX","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743408000000,"name":null,"time":"Pre-Market","dateTimestamp":1743393600000,"actualEps":null},{"market":"US","date":"2025-03-24","symbol":"JAGX","defaultRemindTime":1742823000000,"type":"split","dateTimestamp":1742788800000,"forFactor":25,"toFactor":1,"ratio":25},{"market":"US","date":"2024-11-13","symbol":"JAGX","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":-1.05},{"market":"US","date":"2024-08-13","symbol":"JAGX","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":-4.04}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JAGX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JAGX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1721534400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/JAGX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"JAGX","date":"2025-08-08","current":-0.101191,"percent":0.924652,"low":-14.346047,"twenty":-1.400105,"median":-0.372049,"eighty":-0.169355,"high":-0.028845,"avg":-1.395641,"sd":2.435206,"marketCap":4020303},"quantilePoints":[{"date":"2020-08-14","current":-0.707448,"twenty":-9.422204,"median":-0.380309,"eighty":-0.231704,"marketCap":21710160},{"date":"2020-08-21","current":-0.628436,"twenty":-9.330727,"median":-0.383133,"eighty":-0.23341,"marketCap":19285456},{"date":"2020-08-28","current":-0.552799,"twenty":-9.330727,"median":-0.38765,"eighty":-0.233421,"marketCap":16964298},{"date":"2020-09-04","current":-0.46695,"twenty":-9.330727,"median":-0.391095,"eighty":-0.233695,"marketCap":14329750},{"date":"2020-09-11","current":-0.601083,"twenty":-9.257545,"median":-0.391648,"eighty":-0.234573,"marketCap":18446032},{"date":"2020-09-18","current":-0.548007,"twenty":-9.027021,"median":-0.39479,"eighty":-0.23541,"marketCap":16817231},{"date":"2020-09-25","current":-0.477133,"twenty":-8.233379,"median":-0.400281,"eighty":-0.235771,"marketCap":14642265},{"date":"2020-10-02","current":-0.505773,"twenty":-7.814103,"median":-0.404396,"eighty":-0.236201,"marketCap":15521158},{"date":"2020-10-09","current":-0.604834,"twenty":-7.52144,"median":-0.411827,"eighty":-0.236733,"marketCap":18561160},{"date":"2020-10-16","current":-0.568969,"twenty":-7.287309,"median":-0.414275,"eighty":-0.237417,"marketCap":17460514},{"date":"2020-10-23","current":-0.495172,"twenty":-6.851985,"median":-0.417607,"eighty":-0.238263,"marketCap":15195833},{"date":"2020-10-30","current":-0.373491,"twenty":-6.677293,"median":-0.417519,"eighty":-0.239642,"marketCap":11461704},{"date":"2020-11-06","current":-0.476355,"twenty":-6.631159,"median":-0.414645,"eighty":-0.240382,"marketCap":14618374},{"date":"2020-11-13","current":-0.467332,"twenty":-6.504436,"median":-0.417816,"eighty":-0.24137,"marketCap":14341484},{"date":"2020-11-20","current":-0.472034,"twenty":-6.447513,"median":-0.424988,"eighty":-0.24192,"marketCap":14632573},{"date":"2020-11-27","current":-0.555814,"twenty":-6.417515,"median":-0.429276,"eighty":-0.242282,"marketCap":17229680},{"date":"2020-12-04","current":-0.931394,"twenty":-6.380054,"median":-0.43231,"eighty":-0.242572,"marketCap":28872283},{"date":"2020-12-11","current":-0.939292,"twenty":-6.343471,"median":-0.43516,"eighty":-0.243296,"marketCap":29117106},{"date":"2020-12-18","current":-1.05349,"twenty":-6.326643,"median":-0.439181,"eighty":-0.244095,"marketCap":32657122},{"date":"2020-12-24","current":-2.215427,"twenty":-6.31201,"median":-0.445437,"eighty":-0.244991,"marketCap":68676008},{"date":"2020-12-31","current":-2.852985,"twenty":-6.292255,"median":-0.450597,"eighty":-0.246004,"marketCap":88439679},{"date":"2021-01-08","current":-14.346047,"twenty":-6.358104,"median":-0.459072,"eighty":-0.246137,"marketCap":444713103},{"date":"2021-01-15","current":-12.307903,"twenty":-6.59443,"median":-0.467141,"eighty":-0.246254,"marketCap":381532675},{"date":"2021-01-22","current":-12.084123,"twenty":-6.82616,"median":-0.469996,"eighty":-0.246476,"marketCap":374595717},{"date":"2021-01-29","current":-10.517662,"twenty":-7.75557,"median":-0.476355,"eighty":-0.246524,"marketCap":326037013},{"date":"2021-02-05","current":-10.144696,"twenty":-9.330727,"median":-0.479809,"eighty":-0.246536,"marketCap":314475417},{"date":"2021-02-12","current":-10.666849,"twenty":-9.422204,"median":-0.485088,"eighty":-0.24708,"marketCap":330661652},{"date":"2021-02-19","current":-10.666849,"twenty":-9.623456,"median":-0.487407,"eighty":-0.247137,"marketCap":330661652},{"date":"2021-02-26","current":-7.832302,"twenty":-9.623456,"median":-0.491454,"eighty":-0.247151,"marketCap":242793520},{"date":"2021-03-05","current":-5.967468,"twenty":-9.531978,"median":-0.495172,"eighty":-0.247151,"marketCap":184985539},{"date":"2021-03-12","current":-8.093378,"twenty":-9.4405,"median":-0.500575,"eighty":-0.247458,"marketCap":250886638},{"date":"2021-03-19","current":-7.981488,"twenty":-9.422204,"median":-0.503246,"eighty":-0.247617,"marketCap":247418159},{"date":"2021-03-26","current":-6.862588,"twenty":-9.389717,"median":-0.508595,"eighty":-0.247637,"marketCap":212733370},{"date":"2021-04-01","current":-7.499614,"twenty":-9.351074,"median":-0.510386,"eighty":-0.247637,"marketCap":253554439},{"date":"2021-04-09","current":-7.007215,"twenty":-9.330727,"median":-0.515888,"eighty":-0.247783,"marketCap":236906925},{"date":"2021-04-16","current":-4.923989,"twenty":-9.330727,"median":-0.51778,"eighty":-0.247948,"marketCap":166475136},{"date":"2021-04-23","current":-6.136048,"twenty":-9.27584,"median":-0.52826,"eighty":-0.248274,"marketCap":207453631},{"date":"2021-04-30","current":-6.139838,"twenty":-9.080078,"median":-0.533709,"eighty":-0.249318,"marketCap":207581771},{"date":"2021-05-07","current":-5.326614,"twenty":-8.915551,"median":-0.543343,"eighty":-0.25018,"marketCap":180087497},{"date":"2021-05-14","current":-5.163969,"twenty":-8.652829,"median":-0.549163,"eighty":-0.250418,"marketCap":174588642},{"date":"2021-05-21","current":-4.826414,"twenty":-8.436508,"median":-0.552518,"eighty":-0.251373,"marketCap":182834231},{"date":"2021-05-28","current":-5.806213,"twenty":-8.30224,"median":-0.554602,"eighty":-0.252339,"marketCap":219950955},{"date":"2021-06-04","current":-6.423123,"twenty":-8.197809,"median":-0.556669,"eighty":-0.252571,"marketCap":243320744},{"date":"2021-06-11","current":-6.931167,"twenty":-8.115756,"median":-0.562359,"eighty":-0.252651,"marketCap":262566452},{"date":"2021-06-18","current":-5.87879,"twenty":-8.093378,"median":-0.56269,"eighty":-0.25282,"marketCap":222700341},{"date":"2021-06-25","current":-6.314256,"twenty":-8.07846,"median":-0.566712,"eighty":-0.25313,"marketCap":239196663},{"date":"2021-07-02","current":-5.515902,"twenty":-8.052942,"median":-0.572161,"eighty":-0.253557,"marketCap":208953407},{"date":"2021-07-09","current":-5.987657,"twenty":-8.042343,"median":-0.576292,"eighty":-0.25377,"marketCap":226824422},{"date":"2021-07-16","current":-4.753837,"twenty":-8.011326,"median":-0.582908,"eighty":-0.254192,"marketCap":180084844},{"date":"2021-07-23","current":-5.443325,"twenty":-7.974641,"median":-0.592347,"eighty":-0.254244,"marketCap":206204020},{"date":"2021-07-30","current":-5.080436,"twenty":-7.946642,"median":-0.601083,"eighty":-0.254357,"marketCap":192457085},{"date":"2021-08-06","current":-4.935281,"twenty":-7.921814,"median":-0.604375,"eighty":-0.254391,"marketCap":186958311},{"date":"2021-08-13","current":-3.990062,"twenty":-7.832302,"median":-0.662703,"eighty":-0.25469,"marketCap":170475382},{"date":"2021-08-20","current":-3.636105,"twenty":-7.817383,"median":-0.693062,"eighty":-0.255915,"marketCap":155352566},{"date":"2021-08-27","current":-3.925706,"twenty":-7.757708,"median":-0.72931,"eighty":-0.256055,"marketCap":167725779},{"date":"2021-09-03","current":-3.732638,"twenty":-7.75728,"median":-0.752929,"eighty":-0.256197,"marketCap":159476970},{"date":"2021-09-10","current":-2.788752,"twenty":-7.75557,"median":-0.775055,"eighty":-0.256419,"marketCap":119149448},{"date":"2021-09-17","current":-2.602402,"twenty":-7.720412,"median":-0.90416,"eighty":-0.256579,"marketCap":111187607},{"date":"2021-09-24","current":-2.41883,"twenty":-7.683115,"median":-0.928743,"eighty":-0.256579,"marketCap":103344498},{"date":"2021-10-01","current":-2.35404,"twenty":-7.537491,"median":-0.958083,"eighty":-0.256642,"marketCap":100576342},{"date":"2021-10-08","current":-2.246056,"twenty":-7.499614,"median":-0.985302,"eighty":-0.257041,"marketCap":95962749},{"date":"2021-10-15","current":-2.170468,"twenty":-7.462907,"median":-1.05349,"eighty":-0.258062,"marketCap":92733232},{"date":"2021-10-22","current":-1.954501,"twenty":-7.461737,"median":-1.08173,"eighty":-0.258893,"marketCap":83506045},{"date":"2021-10-29","current":-2.300048,"twenty":-7.348106,"median":-1.089845,"eighty":-0.258893,"marketCap":98269545},{"date":"2021-11-05","current":-2.192064,"twenty":-7.310148,"median":-1.108338,"eighty":-0.258893,"marketCap":93655951},{"date":"2021-11-12","current":-2.040888,"twenty":-7.24341,"median":-1.129467,"eighty":-0.259157,"marketCap":87196920},{"date":"2021-11-19","current":-1.480806,"twenty":-7.082968,"median":-1.140096,"eighty":-0.25916,"marketCap":69673418},{"date":"2021-11-26","current":-1.35332,"twenty":-7.04555,"median":-1.14541,"eighty":-0.260478,"marketCap":63675044},{"date":"2021-12-03","current":-1.157186,"twenty":-7.016659,"median":-1.154482,"eighty":-0.260807,"marketCap":54446777},{"date":"2021-12-10","current":-1.255253,"twenty":-7.008127,"median":-1.159256,"eighty":-0.261077,"marketCap":59060911},{"date":"2021-12-17","current":-1.108153,"twenty":-6.981025,"median":-1.154482,"eighty":-0.261483,"marketCap":52139710},{"date":"2021-12-23","current":-1.137573,"twenty":-6.948491,"median":-1.154482,"eighty":-0.261962,"marketCap":53523950},{"date":"2021-12-31","current":-1.019893,"twenty":-6.931167,"median":-1.14651,"eighty":-0.262386,"marketCap":47986990},{"date":"2022-01-07","current":-0.916923,"twenty":-6.89002,"median":-1.141096,"eighty":-0.262547,"marketCap":43142149},{"date":"2022-01-14","current":-0.943891,"twenty":-6.840731,"median":-1.138238,"eighty":-0.262591,"marketCap":44411036},{"date":"2022-01-21","current":-0.7913,"twenty":-6.822828,"median":-1.13352,"eighty":-0.262917,"marketCap":37231444},{"date":"2022-01-28","current":-0.710787,"twenty":-6.805897,"median":-1.127766,"eighty":-0.263488,"marketCap":33443240},{"date":"2022-02-04","current":-0.776877,"twenty":-6.774449,"median":-1.110386,"eighty":-0.263641,"marketCap":36552858},{"date":"2022-02-11","current":-0.695215,"twenty":-6.737851,"median":-1.104056,"eighty":-0.263904,"marketCap":32710584},{"date":"2022-02-18","current":-0.595741,"twenty":-6.691294,"median":-1.094095,"eighty":-0.264818,"marketCap":28030206},{"date":"2022-02-25","current":-0.503143,"twenty":-6.654638,"median":-1.084584,"eighty":-0.265647,"marketCap":23673365},{"date":"2022-03-04","current":-0.455518,"twenty":-6.63757,"median":-1.056898,"eighty":-0.265747,"marketCap":21432595},{"date":"2022-03-11","current":-0.571741,"twenty":-6.620456,"median":-1.049313,"eighty":-0.266175,"marketCap":30070692},{"date":"2022-03-18","current":-0.873883,"twenty":-6.590051,"median":-1.023862,"eighty":-0.266579,"marketCap":45961895},{"date":"2022-03-25","current":-0.762174,"twenty":-6.531989,"median":-1.014989,"eighty":-0.268065,"marketCap":40086545},{"date":"2022-04-01","current":-0.923727,"twenty":-6.524731,"median":-1.00028,"eighty":-0.269472,"marketCap":48583444},{"date":"2022-04-08","current":-0.850134,"twenty":-6.494485,"median":-0.985302,"eighty":-0.270029,"marketCap":44712805},{"date":"2022-04-14","current":-0.826092,"twenty":-6.489621,"median":-0.964338,"eighty":-0.270149,"marketCap":43448294},{"date":"2022-04-22","current":-0.741087,"twenty":-6.474438,"median":-0.958083,"eighty":-0.270149,"marketCap":38977467},{"date":"2022-04-29","current":-0.663171,"twenty":-6.440782,"median":-0.936443,"eighty":-0.270447,"marketCap":34879496},{"date":"2022-05-06","current":-0.627028,"twenty":-6.439062,"median":-0.931394,"eighty":-0.270685,"marketCap":32978537},{"date":"2022-05-13","current":-0.543049,"twenty":-6.423123,"median":-0.920325,"eighty":-0.271694,"marketCap":31810189},{"date":"2022-05-20","current":-0.530414,"twenty":-6.402004,"median":-0.91202,"eighty":-0.272181,"marketCap":31070055},{"date":"2022-05-27","current":-0.498227,"twenty":-6.401185,"median":-0.899185,"eighty":-0.272374,"marketCap":29184661},{"date":"2022-06-03","current":-0.458593,"twenty":-6.401185,"median":-0.886224,"eighty":-0.272396,"marketCap":26862976},{"date":"2022-06-10","current":-0.453804,"twenty":-6.382422,"median":-0.873883,"eighty":-0.272796,"marketCap":26582504},{"date":"2022-06-17","current":-0.359107,"twenty":-6.367883,"median":-0.856134,"eighty":-0.27324,"marketCap":21035393},{"date":"2022-06-24","current":-0.425608,"twenty":-6.356495,"median":-0.848371,"eighty":-0.273446,"marketCap":24930837},{"date":"2022-07-01","current":-0.409914,"twenty":-6.337521,"median":-0.841485,"eighty":-0.27357,"marketCap":24011511},{"date":"2022-07-08","current":-0.441568,"twenty":-6.327375,"median":-0.836438,"eighty":-0.273619,"marketCap":25865743},{"date":"2022-07-15","current":-0.418958,"twenty":-6.32081,"median":-0.825662,"eighty":-0.27367,"marketCap":24541292},{"date":"2022-07-22","current":-0.421618,"twenty":-6.305456,"median":-0.80419,"eighty":-0.273786,"marketCap":24697110},{"date":"2022-07-29","current":-0.341683,"twenty":-6.292255,"median":-0.800071,"eighty":-0.274141,"marketCap":20014787},{"date":"2022-08-05","current":-0.345806,"twenty":-6.292255,"median":-0.796385,"eighty":-0.274485,"marketCap":20256304},{"date":"2022-08-12","current":-0.385973,"twenty":-6.292255,"median":-0.792546,"eighty":-0.274511,"marketCap":22609152},{"date":"2022-08-19","current":-0.433519,"twenty":-6.290375,"median":-0.78519,"eighty":-0.274541,"marketCap":25394246},{"date":"2022-08-26","current":-0.534609,"twenty":-6.272404,"median":-0.77731,"eighty":-0.275089,"marketCap":28795649},{"date":"2022-09-02","current":-0.490661,"twenty":-6.264829,"median":-0.776877,"eighty":-0.27857,"marketCap":26428482},{"date":"2022-09-09","current":-0.491552,"twenty":-6.264829,"median":-0.776877,"eighty":-0.280154,"marketCap":26476446},{"date":"2022-09-16","current":-0.489771,"twenty":-6.264829,"median":-0.776877,"eighty":-0.282804,"marketCap":26380517},{"date":"2022-09-23","current":-0.37089,"twenty":-6.264829,"median":-0.776877,"eighty":-0.28796,"marketCap":19977246},{"date":"2022-09-30","current":-0.347292,"twenty":-6.264829,"median":-0.776877,"eighty":-0.291841,"marketCap":18706185},{"date":"2022-10-07","current":-0.367551,"twenty":-6.264829,"median":-0.776877,"eighty":-0.293711,"marketCap":19797378},{"date":"2022-10-14","current":-0.313231,"twenty":-6.264829,"median":-0.776877,"eighty":-0.296727,"marketCap":16871539},{"date":"2022-10-21","current":-0.322803,"twenty":-6.264829,"median":-0.776877,"eighty":-0.301028,"marketCap":17387159},{"date":"2022-10-28","current":-0.311004,"twenty":-6.264829,"median":-0.776877,"eighty":-0.303896,"marketCap":16751628},{"date":"2022-11-04","current":-0.296979,"twenty":-6.264829,"median":-0.776877,"eighty":-0.306201,"marketCap":15996186},{"date":"2022-11-11","current":-0.333935,"twenty":-6.264829,"median":-0.776877,"eighty":-0.307268,"marketCap":17986716},{"date":"2022-11-18","current":-0.343695,"twenty":-6.264829,"median":-0.776877,"eighty":-0.311138,"marketCap":18625153},{"date":"2022-11-25","current":-0.306681,"twenty":-6.264829,"median":-0.776877,"eighty":-0.314058,"marketCap":16619367},{"date":"2022-12-02","current":-0.343352,"twenty":-6.264829,"median":-0.776877,"eighty":-0.315356,"marketCap":18606580},{"date":"2022-12-09","current":-0.307063,"twenty":-6.264829,"median":-0.776877,"eighty":-0.31559,"marketCap":16640030},{"date":"2022-12-16","current":-0.294501,"twenty":-6.264829,"median":-0.776877,"eighty":-0.31612,"marketCap":15959301},{"date":"2022-12-23","current":-0.257095,"twenty":-6.264829,"median":-0.776877,"eighty":-0.31612,"marketCap":13932244},{"date":"2022-12-30","current":-0.242579,"twenty":-6.264829,"median":-0.776877,"eighty":-0.31612,"marketCap":13145624},{"date":"2023-01-06","current":-0.24565,"twenty":-6.222455,"median":-0.76702,"eighty":-0.315356,"marketCap":13312024},{"date":"2023-01-13","current":-0.26519,"twenty":-6.163975,"median":-0.749229,"eighty":-0.314573,"marketCap":14370934},{"date":"2023-01-20","current":-0.236438,"twenty":-6.134106,"median":-0.731067,"eighty":-0.31322,"marketCap":12812822},{"date":"2023-01-27","current":-0.174932,"twenty":-6.091044,"median":-0.707448,"eighty":-0.309446,"marketCap":9479751},{"date":"2023-02-03","current":-0.174932,"twenty":-5.981379,"median":-0.688946,"eighty":-0.306726,"marketCap":9479751},{"date":"2023-02-10","current":-0.149995,"twenty":-5.78444,"median":-0.678577,"eighty":-0.303344,"marketCap":8128382},{"date":"2023-02-17","current":-0.119847,"twenty":-5.711862,"median":-0.662703,"eighty":-0.300847,"marketCap":6494638},{"date":"2023-02-24","current":-0.080394,"twenty":-5.537774,"median":-0.628436,"eighty":-0.299208,"marketCap":4356651},{"date":"2023-03-03","current":-0.058435,"twenty":-5.421552,"median":-0.601303,"eighty":-0.296727,"marketCap":3166640},{"date":"2023-03-10","current":-0.043175,"twenty":-5.336928,"median":-0.591502,"eighty":-0.293919,"marketCap":2339683},{"date":"2023-03-17","current":-0.032753,"twenty":-5.271509,"median":-0.576104,"eighty":-0.29245,"marketCap":1774932},{"date":"2023-03-24","current":-0.330097,"twenty":-5.15125,"median":-0.566712,"eighty":-0.28907,"marketCap":15664431},{"date":"2023-03-31","current":-0.183306,"twenty":-5.049676,"median":-0.562474,"eighty":-0.287658,"marketCap":8698611},{"date":"2023-04-06","current":-0.16648,"twenty":-4.926247,"median":-0.556134,"eighty":-0.28293,"marketCap":7900141},{"date":"2023-04-14","current":-0.171767,"twenty":-4.826414,"median":-0.551068,"eighty":-0.281001,"marketCap":8151049},{"date":"2023-04-21","current":-0.171183,"twenty":-4.754612,"median":-0.543343,"eighty":-0.27972,"marketCap":8123324},{"date":"2023-04-28","current":-0.151903,"twenty":-4.610632,"median":-0.534662,"eighty":-0.277979,"marketCap":7208411},{"date":"2023-05-05","current":-0.155671,"twenty":-4.478042,"median":-0.530414,"eighty":-0.274544,"marketCap":7387235},{"date":"2023-05-12","current":-0.280437,"twenty":-4.308934,"median":-0.524163,"eighty":-0.273829,"marketCap":13307835},{"date":"2023-05-19","current":-0.311687,"twenty":-4.171473,"median":-0.518027,"eighty":-0.27363,"marketCap":12988001},{"date":"2023-05-26","current":-0.300316,"twenty":-4.074279,"median":-0.516309,"eighty":-0.27363,"marketCap":12514182},{"date":"2023-06-02","current":-0.261344,"twenty":-4.01456,"median":-0.513146,"eighty":-0.27357,"marketCap":10890204},{"date":"2023-06-09","current":-0.300316,"twenty":-3.925706,"median":-0.51073,"eighty":-0.273154,"marketCap":12514182},{"date":"2023-06-16","current":-0.32049,"twenty":-3.86135,"median":-0.505941,"eighty":-0.273154,"marketCap":13354829},{"date":"2023-06-23","current":-0.210726,"twenty":-3.742236,"median":-0.501033,"eighty":-0.272471,"marketCap":8780943},{"date":"2023-06-30","current":-0.228791,"twenty":-3.692602,"median":-0.498892,"eighty":-0.271724,"marketCap":9533705},{"date":"2023-07-07","current":-0.238419,"twenty":-3.661847,"median":-0.495172,"eighty":-0.270209,"marketCap":9934923},{"date":"2023-07-14","current":-0.247589,"twenty":-3.551338,"median":-0.491552,"eighty":-0.266579,"marketCap":10317035},{"date":"2023-07-21","current":-0.245847,"twenty":-3.40739,"median":-0.488071,"eighty":-0.264451,"marketCap":10244434},{"date":"2023-07-28","current":-0.277758,"twenty":-2.863834,"median":-0.484742,"eighty":-0.263662,"marketCap":11574185},{"date":"2023-08-04","current":-0.271431,"twenty":-2.67799,"median":-0.477836,"eighty":-0.263662,"marketCap":11310528},{"date":"2023-08-11","current":-0.26868,"twenty":-2.559656,"median":-0.47203,"eighty":-0.263627,"marketCap":11195894},{"date":"2023-08-18","current":-0.214984,"twenty":-2.519028,"median":-0.467141,"eighty":-0.262224,"marketCap":9556697},{"date":"2023-08-25","current":-0.179333,"twenty":-2.479084,"median":-0.464656,"eighty":-0.260807,"marketCap":7971880},{"date":"2023-09-01","current":-0.165571,"twenty":-2.430422,"median":-0.458593,"eighty":-0.258893,"marketCap":7360129},{"date":"2023-09-08","current":-0.143638,"twenty":-2.41883,"median":-0.453804,"eighty":-0.256996,"marketCap":6385151},{"date":"2023-09-15","current":-0.132457,"twenty":-2.310846,"median":-0.445425,"eighty":-0.256579,"marketCap":5888103},{"date":"2023-09-22","current":-0.125146,"twenty":-2.267653,"median":-0.438838,"eighty":-0.255586,"marketCap":5563110},{"date":"2023-09-29","current":-0.113534,"twenty":-2.239577,"median":-0.436302,"eighty":-0.254205,"marketCap":5046945},{"date":"2023-10-06","current":-0.101063,"twenty":-2.200703,"median":-0.431468,"eighty":-0.252714,"marketCap":4492546},{"date":"2023-10-13","current":-0.152239,"twenty":-2.170468,"median":-0.425542,"eighty":-0.252307,"marketCap":6767495},{"date":"2023-10-20","current":-0.151379,"twenty":-2.114316,"median":-0.421693,"eighty":-0.250918,"marketCap":6729261},{"date":"2023-10-27","current":-0.147896,"twenty":-2.032936,"median":-0.419357,"eighty":-0.249888,"marketCap":6574411},{"date":"2023-11-02","current":-0.149444,"twenty":-1.967302,"median":-0.418358,"eighty":-0.247971,"marketCap":6643233},{"date":"2023-11-10","current":-0.129446,"twenty":-1.858324,"median":-0.414303,"eighty":-0.247589,"marketCap":5754282},{"date":"2023-11-17","current":-0.175714,"twenty":-1.761881,"median":-0.409648,"eighty":-0.247381,"marketCap":6977784},{"date":"2023-11-24","current":-0.477635,"twenty":-1.688918,"median":-0.409648,"eighty":-0.247381,"marketCap":18967360},{"date":"2023-12-01","current":-0.4522,"twenty":-1.58869,"median":-0.409648,"eighty":-0.247381,"marketCap":17957324},{"date":"2023-12-08","current":-0.367461,"twenty":-1.537808,"median":-0.408897,"eighty":-0.247458,"marketCap":14592229},{"date":"2023-12-15","current":-0.212935,"twenty":-1.516939,"median":-0.402106,"eighty":-0.246971,"marketCap":8455879},{"date":"2023-12-22","current":-0.195425,"twenty":-1.515112,"median":-0.40039,"eighty":-0.24631,"marketCap":7760528},{"date":"2024-01-05","current":-0.191207,"twenty":-1.50625,"median":-0.396526,"eighty":-0.245818,"marketCap":7593034},{"date":"2024-01-12","current":-0.138549,"twenty":-1.450186,"median":-0.391544,"eighty":-0.244219,"marketCap":5501904},{"date":"2024-01-19","current":-0.134331,"twenty":-1.421553,"median":-0.388891,"eighty":-0.242591,"marketCap":5334411},{"date":"2024-01-26","current":-0.146984,"twenty":-1.400293,"median":-0.385885,"eighty":-0.240931,"marketCap":5836891},{"date":"2024-02-02","current":-0.127429,"twenty":-1.400293,"median":-0.385885,"eighty":-0.238089,"marketCap":5060331},{"date":"2024-02-09","current":-0.11337,"twenty":-1.400293,"median":-0.385885,"eighty":-0.2366,"marketCap":4502019},{"date":"2024-02-16","current":-0.104806,"twenty":-1.400293,"median":-0.385885,"eighty":-0.235101,"marketCap":4161957},{"date":"2024-02-23","current":-0.072853,"twenty":-1.400293,"median":-0.385885,"eighty":-0.233827,"marketCap":2893068},{"date":"2024-03-01","current":-0.075409,"twenty":-1.399637,"median":-0.38496,"eighty":-0.233585,"marketCap":2994579},{"date":"2024-03-08","current":-0.104423,"twenty":-1.399637,"median":-0.38496,"eighty":-0.233585,"marketCap":4146730},{"date":"2024-03-15","current":-0.114899,"twenty":-1.399637,"median":-0.38496,"eighty":-0.233585,"marketCap":4562744},{"date":"2024-03-22","current":-0.411317,"twenty":-1.399637,"median":-0.382043,"eighty":-0.233892,"marketCap":16333822},{"date":"2024-03-28","current":-0.425451,"twenty":-1.399637,"median":-0.383584,"eighty":-0.233892,"marketCap":16895102},{"date":"2024-04-05","current":-0.434334,"twenty":-1.400293,"median":-0.383133,"eighty":-0.233827,"marketCap":17938010},{"date":"2024-04-12","current":-0.718965,"twenty":-1.35332,"median":-0.383133,"eighty":-0.233827,"marketCap":29693248},{"date":"2024-04-19","current":-1.184453,"twenty":-1.317325,"median":-0.383133,"eighty":-0.233827,"marketCap":48917901},{"date":"2024-04-26","current":-1.136968,"twenty":-1.288596,"median":-0.383584,"eighty":-0.233892,"marketCap":46956765},{"date":"2024-05-03","current":-1.960935,"twenty":-1.284461,"median":-0.383584,"eighty":-0.233892,"marketCap":80986610},{"date":"2024-05-10","current":-2.06995,"twenty":-1.288596,"median":-0.383584,"eighty":-0.233892,"marketCap":85488935},{"date":"2024-05-17","current":-2.066361,"twenty":-1.347436,"median":-0.383584,"eighty":-0.233892,"marketCap":79191204},{"date":"2024-05-24","current":-0.654468,"twenty":-1.347436,"median":-0.383584,"eighty":-0.233892,"marketCap":25081821},{"date":"2024-05-31","current":-0.547302,"twenty":-1.347436,"median":-0.383584,"eighty":-0.233892,"marketCap":20974818},{"date":"2024-06-07","current":-0.486066,"twenty":-1.347436,"median":-0.383584,"eighty":-0.233892,"marketCap":18627985},{"date":"2024-06-14","current":-0.511421,"twenty":-1.349397,"median":-0.383133,"eighty":-0.233827,"marketCap":19599688},{"date":"2024-06-21","current":-0.54864,"twenty":-1.351359,"median":-0.382043,"eighty":-0.233761,"marketCap":21026081},{"date":"2024-06-28","current":-0.499014,"twenty":-1.35332,"median":-0.380954,"eighty":-0.233585,"marketCap":19124224},{"date":"2024-07-05","current":-0.482472,"twenty":-1.35332,"median":-0.380954,"eighty":-0.233585,"marketCap":18490272},{"date":"2024-07-12","current":-0.563803,"twenty":-1.35332,"median":-0.380954,"eighty":-0.233585,"marketCap":21607204},{"date":"2024-07-15","current":-0.561046,"twenty":-1.35332,"median":-0.380954,"eighty":-0.233585,"marketCap":21501545},{"date":"2024-08-02","current":-0.178169,"twenty":-1.391113,"median":-0.386838,"eighty":-0.231471,"marketCap":6828131},{"date":"2024-08-09","current":-0.166191,"twenty":-1.391113,"median":-0.386838,"eighty":-0.228719,"marketCap":6369097},{"date":"2024-08-16","current":-0.189838,"twenty":-1.391113,"median":-0.386838,"eighty":-0.226472,"marketCap":6770752},{"date":"2024-08-23","current":-0.318699,"twenty":-1.391113,"median":-0.386838,"eighty":-0.226472,"marketCap":11366714},{"date":"2024-08-30","current":-0.290197,"twenty":-1.391113,"median":-0.386838,"eighty":-0.226472,"marketCap":10350178},{"date":"2024-09-06","current":-0.290197,"twenty":-1.391113,"median":-0.386838,"eighty":-0.226472,"marketCap":10350178},{"date":"2024-09-13","current":-0.287606,"twenty":-1.391113,"median":-0.386838,"eighty":-0.226472,"marketCap":10257766},{"date":"2024-09-20","current":-0.287606,"twenty":-1.391113,"median":-0.386838,"eighty":-0.226472,"marketCap":10257766},{"date":"2024-09-27","current":-0.301857,"twenty":-1.391113,"median":-0.386838,"eighty":-0.226472,"marketCap":10766034},{"date":"2024-10-04","current":-0.339427,"twenty":-1.391113,"median":-0.38496,"eighty":-0.226472,"marketCap":12106012},{"date":"2024-10-11","current":-0.326472,"twenty":-1.391113,"median":-0.38496,"eighty":-0.226472,"marketCap":11643951},{"date":"2024-10-18","current":-0.318699,"twenty":-1.391113,"median":-0.38496,"eighty":-0.227855,"marketCap":11366714},{"date":"2024-10-25","current":-0.292788,"twenty":-1.391113,"median":-0.38496,"eighty":-0.227855,"marketCap":10442591},{"date":"2024-10-31","current":-0.274651,"twenty":-1.391113,"median":-0.38496,"eighty":-0.227855,"marketCap":9795704},{"date":"2024-11-08","current":-0.256514,"twenty":-1.393361,"median":-0.385885,"eighty":-0.227809,"marketCap":9148818},{"date":"2024-11-15","current":-0.254647,"twenty":-1.393361,"median":-0.385885,"eighty":-0.227809,"marketCap":9610880},{"date":"2024-11-22","current":-0.241106,"twenty":-1.393361,"median":-0.385885,"eighty":-0.229676,"marketCap":9099840},{"date":"2024-11-29","current":-0.325108,"twenty":-1.393361,"median":-0.385885,"eighty":-0.233513,"marketCap":12270219},{"date":"2024-12-06","current":-0.309071,"twenty":-1.393361,"median":-0.385885,"eighty":-0.236761,"marketCap":11664967},{"date":"2024-12-13","current":-0.30482,"twenty":-1.393361,"median":-0.385973,"eighty":-0.238275,"marketCap":11504510},{"date":"2024-12-20","current":-0.272934,"twenty":-1.393361,"median":-0.385973,"eighty":-0.239941,"marketCap":10301085},{"date":"2024-12-27","current":-0.33136,"twenty":-1.393361,"median":-0.385973,"eighty":-0.240042,"marketCap":12506185},{"date":"2025-01-03","current":-0.340738,"twenty":-1.393361,"median":-0.385973,"eighty":-0.240042,"marketCap":12860133},{"date":"2025-01-10","current":-0.340738,"twenty":-1.395609,"median":-0.386838,"eighty":-0.240017,"marketCap":12860133},{"date":"2025-01-17","current":-0.268714,"twenty":-1.395609,"median":-0.386838,"eighty":-0.240017,"marketCap":10141808},{"date":"2025-01-24","current":-0.257273,"twenty":-1.395609,"median":-0.385929,"eighty":-0.240017,"marketCap":9709991},{"date":"2025-01-31","current":-0.281343,"twenty":-1.395609,"median":-0.385929,"eighty":-0.240017,"marketCap":10618459},{"date":"2025-02-07","current":-0.263994,"twenty":-1.395609,"median":-0.385929,"eighty":-0.240017,"marketCap":9963654},{"date":"2025-02-14","current":-0.267276,"twenty":-1.395609,"median":-0.385929,"eighty":-0.240017,"marketCap":10087536},{"date":"2025-02-21","current":-0.275498,"twenty":-1.395609,"median":-0.385929,"eighty":-0.240017,"marketCap":10397831},{"date":"2025-02-28","current":-0.179966,"twenty":-1.395609,"median":-0.385929,"eighty":-0.23843,"marketCap":6792274},{"date":"2025-03-07","current":-0.180998,"twenty":-1.397857,"median":-0.385973,"eighty":-0.237432,"marketCap":6831208},{"date":"2025-03-14","current":-0.155706,"twenty":-1.397857,"median":-0.385973,"eighty":-0.237432,"marketCap":5876641},{"date":"2025-03-21","current":-0.086349,"twenty":-1.397857,"median":-0.385973,"eighty":-0.237432,"marketCap":3258983},{"date":"2025-03-28","current":-0.074628,"twenty":-1.397857,"median":-0.385973,"eighty":-0.237059,"marketCap":2816596},{"date":"2025-04-04","current":-0.061885,"twenty":-1.397857,"median":-0.385973,"eighty":-0.2366,"marketCap":2382066},{"date":"2025-04-11","current":-0.089658,"twenty":-1.395609,"median":-0.385929,"eighty":-0.23382,"marketCap":3451100},{"date":"2025-04-17","current":-0.098261,"twenty":-1.395609,"median":-0.385929,"eighty":-0.228417,"marketCap":3782257},{"date":"2025-04-25","current":-0.141141,"twenty":-1.397857,"median":-0.385973,"eighty":-0.218296,"marketCap":5432786},{"date":"2025-05-02","current":-0.207859,"twenty":-1.397857,"median":-0.385973,"eighty":-0.215001,"marketCap":8000890},{"date":"2025-05-09","current":-0.15226,"twenty":-1.397857,"median":-0.385973,"eighty":-0.213039,"marketCap":5860803},{"date":"2025-05-16","current":-0.096312,"twenty":-1.397857,"median":-0.385973,"eighty":-0.208699,"marketCap":3707236},{"date":"2025-05-23","current":-0.144196,"twenty":-1.397857,"median":-0.385973,"eighty":-0.199939,"marketCap":5728900},{"date":"2025-05-30","current":-0.147061,"twenty":-1.397857,"median":-0.385973,"eighty":-0.194699,"marketCap":5842719},{"date":"2025-06-06","current":-0.124142,"twenty":-1.397857,"median":-0.385973,"eighty":-0.191412,"marketCap":4932166},{"date":"2025-06-13","current":-0.121914,"twenty":-1.397857,"median":-0.385973,"eighty":-0.18811,"marketCap":4843640},{"date":"2025-06-20","current":-0.088491,"twenty":-1.400105,"median":-0.386239,"eighty":-0.184618,"marketCap":3515749},{"date":"2025-06-27","current":-0.090343,"twenty":-1.400105,"median":-0.386239,"eighty":-0.182879,"marketCap":3589316},{"date":"2025-07-03","current":-0.086009,"twenty":-1.400105,"median":-0.386239,"eighty":-0.180472,"marketCap":3417135},{"date":"2025-07-11","current":-0.087676,"twenty":-1.400105,"median":-0.385929,"eighty":-0.179016,"marketCap":3483358},{"date":"2025-07-18","current":-0.077341,"twenty":-1.400105,"median":-0.382495,"eighty":-0.176152,"marketCap":3072772},{"date":"2025-07-25","current":-0.077008,"twenty":-1.400105,"median":-0.379841,"eighty":-0.173677,"marketCap":3059528},{"date":"2025-08-01","current":-0.068007,"twenty":-1.400105,"median":-0.378758,"eighty":-0.172046,"marketCap":2701920},{"date":"2025-08-08","current":-0.101191,"twenty":-1.400105,"median":-0.372049,"eighty":-0.169355,"marketCap":4020303}],"updateTime":1754764596942},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JAGX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2558857913","title":"Jaguar Health Inc  expected to post a loss of $7.13 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2558857913","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558857913?lang=en_us&edition=fundamental","pubTime":"2025-08-09 01:50","pubTimestamp":1754675456,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc  expected to post a loss of $7.13 a share - Earnings Preview Jaguar Health Inc JAGX.OQ JAGX.O is expected to  show a rise in quarterly revenue when it reports  results on August 11 (","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL8N3U035O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JAGX"],"gpt_icon":0},{"id":"2553476972","title":"Jaguar Health Inc. Announces Date for 2025 Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2553476972","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553476972?lang=en_us&edition=fundamental","pubTime":"2025-07-21 19:02","pubTimestamp":1753095730,"startTime":"0","endTime":"0","summary":"Jaguar Health, Inc. is set to hold its 2025 Annual Meeting of Stockholders on August 19, 2025, in San Francisco, California. During the meeting, stockholders will be asked to elect three Class I directors to the Board of Directors, ratify the appointment of RBSM LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025, and approve an amendment and restatement of the company's stock incentive plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 21, 2025, and is sol","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250721:nNDL1pPrfm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JAGX","BK4007"],"gpt_icon":0},{"id":"2550362886","title":"Jaguar Health Inc. Advances European Approval Process for Canalevia with EMA Dossier Submission for General Diarrhea Treatment in Dogs","url":"https://stock-news.laohu8.com/highlight/detail?id=2550362886","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550362886?lang=en_us&edition=fundamental","pubTime":"2025-07-10 20:30","pubTimestamp":1752150647,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc. Advances European Approval Process for Canalevia with EMA Dossier Submission for General Diarrhea Treatment in Dogs. Jaguar Health Inc. has announced ongoing regulatory efforts regarding its conditionally approved Canalevia-CA1 prescription drug, which targets chemotherapy-induced diarrhea  in dogs. The company is actively engaging with multiple potential animal health partners to expand the drug's approval and commercialization for general diarrhea treatment globally. Jaguar Health plans to submit a dossier to the European Medicines Agency  based on updated study analysis. If accepted, they will proceed with a Marketing Authorization Application  for Canalevia in the EU. Successful approval would allow the drug to be marketed across all 27 EU member countries.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250710:nNDL8pKlcG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JAGX"],"gpt_icon":0},{"id":"2549540791","title":"Jaguar Health announces coca access, benefit sharing agreement authorization","url":"https://stock-news.laohu8.com/highlight/detail?id=2549540791","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549540791?lang=en_us&edition=fundamental","pubTime":"2025-07-08 21:10","pubTimestamp":1751980220,"startTime":"0","endTime":"0","summary":"Jaguar Health (JAGX) announced that an access and benefit sharing agreement focused on two cultivated species of the coca plant – Erythroxylum coca...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jaguar-health-announces-coca-access-benefit-sharing-agreement-authorization-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jaguar-health-announces-coca-access-benefit-sharing-agreement-authorization-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","JAGX"],"gpt_icon":0},{"id":"2548016015","title":"Jaguar Health Inc. Announces Amendment to Existing Royalty Interest Agreement with Iliad Research, Reducing Outstanding Balance by $4.25 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2548016015","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548016015?lang=en_us&edition=fundamental","pubTime":"2025-07-01 00:10","pubTimestamp":1751299813,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc. Announces Amendment to Existing Royalty Interest Agreement with Iliad Research, Reducing Outstanding Balance by $4.25 Million. Jaguar Health Inc. has recently entered into a significant financial agreement involving a privately negotiated exchange with Iliad Research and Trading, L.P. The agreement, known as the Iliad Series M Exchange Agreement, was finalized on June 27, 2025. As part of this arrangement, Jaguar Health issued 170 shares of Series M Perpetual Preferred Stock to Iliad, resulting in a $4,250,000 reduction in the outstanding balance of a previously established royalty interest. This move marks a strategic financial maneuver for Jaguar Health, aiming to optimize its financial obligations while maintaining operational flexibility.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDL3DlfG7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JAGX"],"gpt_icon":0},{"id":"2547940830","title":"Jaguar Health Announces Promising Results from Crofelemer Clinical Trials in Intestinal Failure Patients, Plans for Expedited Regulatory Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2547940830","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547940830?lang=en_us&edition=fundamental","pubTime":"2025-06-30 21:05","pubTimestamp":1751288743,"startTime":"0","endTime":"0","summary":"Jaguar Health Announces Promising Results from Crofelemer Clinical Trials in Intestinal Failure Patients, Plans for Expedited Regulatory Approval. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via ACCESS Newswire  on June 30, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDL1XhjWz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JAGX","BK4007"],"gpt_icon":0},{"id":"2546524818","title":"Jaguar Health Inc. Pursues EMA Approval for Canalevia to Treat General Diarrhea in Dogs Across EU","url":"https://stock-news.laohu8.com/highlight/detail?id=2546524818","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546524818?lang=en_us&edition=fundamental","pubTime":"2025-06-25 21:00","pubTimestamp":1750856441,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO, CA / June 25, 2025 / Jaguar Health, Inc.  has announced its plan to pursue regulatory approval for Canalevia  in the European Union for treating general diarrhea in dogs. Currently conditionally approved by the U.S. FDA for chemotherapy-induced diarrhea in dogs, Jaguar aims to expand Canalevia's indications and availability. The company intends to submit a dossier to the European Medicines Agency's  Committee for Veterinary Medicinal Products , followed by a Marketing Authorization Application  if the results are favorable. Successful approval would allow Canalevia to be marketed for general diarrhea treatment in dogs across all 27 EU member countries. Jaguar is actively in discussions with multiple potential animal health company partners to collaborate on achieving these regulatory and commercialization goals globally.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and time","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nNDL7nxsYh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JAGX","BK4007"],"gpt_icon":0},{"id":"2546258060","title":"Jaguar Health Inc. Extends Maturity Date of Convertible Promissory Notes to January 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2546258060","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546258060?lang=en_us&edition=fundamental","pubTime":"2025-06-25 04:15","pubTimestamp":1750796152,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc.  has announced an extension of the maturity date for its convertible promissory notes from the recent bridge financing. The new maturity date is set for January 30, 2026, extending from the previous date of June 30, 2025. This change affects approximately $2.57 million in aggregate principal amount of the notes, which were part of a $3.448 million bridge financing deal that closed on March 31, 2025. Prior to this extension, five investors converted $0.866 million of the original financing into equity. CEO Lisa Conte expressed satisfaction with the agreement, highlighting the investors' commitment to supporting Jaguar's development programs for its plant-based medicine, crofelemer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or leg","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nNDL7n8jyp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JAGX"],"gpt_icon":0},{"id":"2545883412","title":"Jaguar Health Inc. Announces Progress in Clinical Trials for Crofelemer, Targeting Intestinal Failure in Rare Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2545883412","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545883412?lang=en_us&edition=fundamental","pubTime":"2025-06-23 21:00","pubTimestamp":1750683622,"startTime":"0","endTime":"0","summary":"Jaguar Health, Inc.  has announced updates regarding their clinical development program for crofelemer, aimed at treating intestinal failure due to microvillus inclusion disease  and short bowel syndrome . The company is conducting two placebo-controlled Phase 2 studies in the United States, European Union, and Middle East/North Africa regions. Enrollment for the Phase 2 study on crofelemer's efficacy in pediatric MVID patients has reached approximately 25%, with completion expected in mid-2026. Additionally, enrollment for the SBS-IF study in adults has surpassed 10%. Initial proof-of-concept results from independent investigator-initiated trials indicate a reduction in required total parenteral nutrition for patients with MVID and SBS by up to 27% and 12.5%, respectively. Further data from these trials are anticipated as enrollment continues.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250623:nNDL9l2yb9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JAGX","BK4007"],"gpt_icon":0},{"id":"2545108955","title":"Jaguar Health files to sell 507.4K shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2545108955","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545108955?lang=en_us&edition=fundamental","pubTime":"2025-06-21 04:40","pubTimestamp":1750452019,"startTime":"0","endTime":"0","summary":"16:35 EDT Jaguar Health (JAGX) files to sell 507.4K shares of common stock for holders Published first on TheFly – the ultimate source for real-tim...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jaguar-health-files-to-sell-507-4k-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jaguar-health-files-to-sell-507-4k-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JAGX","BK4007"],"gpt_icon":0},{"id":"2544825960","title":"Jaguar Health Inc. to Present at the Emerging Growth Conference for Updates on Near-Term Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2544825960","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544825960?lang=en_us&edition=fundamental","pubTime":"2025-06-17 21:00","pubTimestamp":1750165218,"startTime":"0","endTime":"0","summary":"Jaguar Health, Inc.  will be participating in the Emerging Growth Conference on June 18, 2025. Lisa Conte, the company's founder, president, and CEO, is scheduled to present virtually, providing updates on near-term catalysts for the company. An archived webcast of the presentation will be accessible on EmergingGrowth.com and the Emerging Growth YouTube Channel.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via ACCESS Newswire  on June 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nNDL31gzJw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JAGX","BK4007"],"gpt_icon":0},{"id":"2542538345","title":"Jaguar Health Inc. Establishes First Study Site for Canalevia-CA1 Field Study Amid Ongoing FDA Review for Expanded Canine Diarrhea Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2542538345","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542538345?lang=en_us&edition=fundamental","pubTime":"2025-06-11 22:11","pubTimestamp":1749651098,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc. Establishes First Study Site for Canalevia-CA1 Field Study Amid Ongoing FDA Review for Expanded Canine Diarrhea Treatment Approval. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via ACCESS Newswire  on June 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nNDL9DqlFZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JAGX"],"gpt_icon":0},{"id":"2542820313","title":"Jaguar Health Pursues FDA Orphan Drug Designation and Expanded Access for Crofelemer in Metastatic Breast Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2542820313","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542820313?lang=en_us&edition=fundamental","pubTime":"2025-06-09 21:00","pubTimestamp":1749474036,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO, CA / ACCESS Newswire / June 9, 2025 / Jaguar Health, Inc. , through its subsidiary Napo Pharmaceuticals, announced a promising regulatory development following an in-person Type C Meeting with the U.S. Food and Drug Administration . The meeting focused on the statistically significant results from Napo's Phase 3 OnTarget trial targeting cancer therapy-related diarrhea  in adult patients with metastatic breast cancer. Jaguar Health has proposed two potential pathways to make their drug, crofelemer, available to this patient population. These include conducting a pivotal treatment trial and pursuing authorization for an expanded access program. The FDA has formally acknowledged these proposals, marking a significant step toward potential approval. Crofelemer has already been granted orphan drug designation in the US and EU for other conditions, offering development incentives and marketing exclusivity upon approval.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nNDLcbxydr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JAGX"],"gpt_icon":0},{"id":"2541850288","title":"Jaguar Health Inc. to Participate in Virtual Fireside Chat at Lytham Partners' Spring 2025 Spotlight Series","url":"https://stock-news.laohu8.com/highlight/detail?id=2541850288","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541850288?lang=en_us&edition=fundamental","pubTime":"2025-06-06 21:00","pubTimestamp":1749214834,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc. will participate in a virtual fireside chat on June 10, 2025, as part of Lytham Partners' Spring 2025 Spotlight Series. Lisa Conte, the company's founder, president, and CEO, will discuss Jaguar's efforts to further its orphan disease development programs during the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via ACCESS Newswire  on June 06, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250606:nNDLcdXPnz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JAGX"],"gpt_icon":0},{"id":"2538988284","title":"Jaguar Health Inc. Releases Investor Presentation Highlighting Operational Strategies and Financial Overview","url":"https://stock-news.laohu8.com/highlight/detail?id=2538988284","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538988284?lang=en_us&edition=fundamental","pubTime":"2025-05-27 23:16","pubTimestamp":1748358963,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc. has released a corporate presentation providing an overview of its current financial status and business operations. The presentation highlights potential risks, including limitations on cash transfers between Sigma and its subsidiaries, reliance on consultants for mineral exploration, and impacts of the COVID-19 pandemic on its business. It also addresses challenges related to currency fluctuations, potential litigation, and conflicts of interest among its directors and officers. Furthermore, the presentation discusses the volatility of Sigma's share price and the company's need for future financing to maintain operations. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250527:nNDL4bFtds:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JAGX"],"gpt_icon":0},{"id":"2537938601","title":"Jaguar Health Prices Offering of Shares, Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2537938601","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537938601?lang=en_us&edition=fundamental","pubTime":"2025-05-21 20:27","pubTimestamp":1747830444,"startTime":"0","endTime":"0","summary":"Jaguar Health  said Wednesday it has agreed to the purchase and sale of 246,306 shares of common stock at a price of $6.09 per share in a registered direct offering.In a simultaneous private placement, the company said it agreed to issue unregistered warrants to purchase up to 492,612 shares at an exercise price of $5.84 per share.The offering is expected to close Thursday, the company said.The proceeds to the company from the offering are expected to be about $1.5 million, which the company said it expects to use for general corporate purposes.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","JAGX"],"gpt_icon":0},{"id":"2537957938","title":"Jaguar Health prices 246,306 shares at $6.09 in registered direct offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2537957938","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537957938?lang=en_us&edition=fundamental","pubTime":"2025-05-21 20:20","pubTimestamp":1747830038,"startTime":"0","endTime":"0","summary":"Jaguar Health (JAGX) entered into definitive agreements for the purchase and sale of 246,306 shares of common stock at a purchase price of $6.09 pe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jaguar-health-prices-246306-shares-at-6-09-in-registered-direct-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jaguar-health-prices-246306-shares-at-6-09-in-registered-direct-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","JAGX"],"gpt_icon":0},{"id":"2537980106","title":"Jaguar Health Inc. Announces $1.5 Million Registered Direct Offering, Issuing 246,306 Shares at $6.09 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2537980106","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537980106?lang=en_us&edition=fundamental","pubTime":"2025-05-21 20:02","pubTimestamp":1747828932,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc. has announced a $1.5 million registered direct offering, involving the sale of 246,306 shares of common stock at $6.09 per share. As part of a concurrent private placement, the company will issue unregistered warrants to purchase an additional 492,612 shares at an exercise price of $5.84 per share. The offering is expected to close soon, pending customary conditions. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering. Jaguar Health plans to use the proceeds for general corporate purposes, including growth capital and operating expenses.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via ACCESS Newswire  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL8x4Rk1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JAGX"],"gpt_icon":0},{"id":"2536853643","title":"Jaguar Health announces first patient randomized in crofelemer trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2536853643","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536853643?lang=en_us&edition=fundamental","pubTime":"2025-05-20 21:25","pubTimestamp":1747747525,"startTime":"0","endTime":"0","summary":"Jaguar Health (JAGX) family companies Napo Pharmaceuticals and Napo Therapeutics announced that the first patient has been randomized in Napo’s ran...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jaguar-health-announces-first-patient-randomized-in-crofelemer-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jaguar-health-announces-first-patient-randomized-in-crofelemer-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JAGX","BK4007"],"gpt_icon":0},{"id":"2536648582","title":"Jaguar Health Inc. Launches Phase 2 Clinical Trial for Crofelemer in Pediatric MVID Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2536648582","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536648582?lang=en_us&edition=fundamental","pubTime":"2025-05-20 21:17","pubTimestamp":1747747069,"startTime":"0","endTime":"0","summary":"Jaguar Health Inc., along with its family companies Napo Pharmaceuticals, Inc. and Napo Therapeutics S.p.A., has announced the randomization of the first patient in a Phase 2 clinical trial evaluating crofelemer for pediatric patients with Microvillus Inclusion Disease . This double-blind, placebo-controlled study aims to assess the safety and efficacy of crofelemer, a novel antisecretory drug derived from the Croton lechleri tree, in reducing the need for total parenteral nutrition in patients with this ultrarare condition. Initial proof-of-concept results from an independent trial in Abu Dhabi indicated a 27% reduction in parenteral support. Results from the ongoing Phase 2 trial are expected in the second half of 2026. Jaguar Health is also exploring pathways for expedited regulatory approval in Europe and the U.S. through programs like PRIME and Breakthrough Therapy designation.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nNDL6k2ywR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JAGX"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":56,"code":"91000000","status":"200"}]}}